|
NCOR1 |
nuclear receptor corepressor 1 |
- Nuclear signaling by ERBB4
- Nuclear signaling by ERBB4
- NR1D1 (REV-ERBA) represses gene expression
- PPARA activates gene expression
- PPARA activates gene expression
- NOTCH1 Intracellular Domain Regulates Transcription
- Transcriptional activation of mitochondrial biogenesis
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- HDACs deacetylate histones
- Notch-HLH transcription pathway
- Transcriptional regulation of white adipocyte differentiation
- Transcriptional regulation of white adipocyte differentiation
- Nuclear Receptor transcription pathway
- Regulation of lipid metabolism by PPARalpha
- Circadian Clock
- Circadian Clock
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
- Loss of MECP2 binding ability to the NCoR/SMRT complex
- Regulation of MECP2 expression and activity
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
- HCMV Early Events
- NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
|
|
|
|
NFKB1 |
nuclear factor kappa B subunit 1 |
- Activation of NF-kappaB in B cells
- RIP-mediated NFkB activation via ZBP1
- Regulated proteolysis of p75NTR
- Downstream TCR signaling
- NF-kB is activated and signals survival
- Senescence-Associated Secretory Phenotype (SASP)
- FCERI mediated NF-kB activation
- DEx/H-box helicases activate type I IFN and inflammatory cytokines production
- PKMTs methylate histone lysines
- Transcriptional regulation of white adipocyte differentiation
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
- Interleukin-1 processing
- IkBA variant leads to EDA-ID
- CLEC7A (Dectin-1) signaling
- CD209 (DC-SIGN) signaling
- CLEC7A/inflammasome pathway
- MAP3K8 (TPL2)-dependent MAPK1/3 activation
- Neutrophil degranulation
- The NLRP3 inflammasome
- Transcriptional Regulation by VENTX
- Interleukin-1 signaling
- TRAF6 mediated NF-kB activation
- HCMV Early Events
- Purinergic signaling in leishmaniasis infection
|
- Donepezil
- Pseudoephedrine
- Thalidomide
- Pranlukast
- HE3286
- P54
- NOX-700
- SGN-30
- Custirsen
- NF-kappaB Decoy
- Andrographolide
- Triflusal
- Glycyrrhizic acid
- Fish oil
- SC-236
|
|
|
NKX2-1 |
NK2 homeobox 1 |
|
|
- Choreoathetosis, hypothyroidism, and neonatal respiratory distress
|
|
NR1H2 |
nuclear receptor subfamily 1 group H member 2 |
- PPARA activates gene expression
- Nuclear Receptor transcription pathway
- SUMOylation of intracellular receptors
- VLDLR internalisation and degradation
- NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
- NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake
- NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose
- NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
|
- GW-3965
- Benzenesulfinic acid
- TO-901317
- 1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL
- Diacerein
- Rhein
|
|
|
NR1H3 |
nuclear receptor subfamily 1 group H member 3 |
- PPARA activates gene expression
- VLDLR internalisation and degradation
- NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
- NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake
- NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose
- NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
- NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis
|
- TO-901317
- N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE
- 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE
- (2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID
- Diacerein
- Rhein
|
|
|
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
- Recycling of bile acids and salts
- Synthesis of bile acids and bile salts
- Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
- Synthesis of bile acids and bile salts via 27-hydroxycholesterol
- PPARA activates gene expression
- Endogenous sterols
|
- alpha-Linolenic acid
- Ursodeoxycholic acid
- Farnesol
- Fexaramine
- Cholic Acid
- Deoxycholic acid
- Taurocholic acid
- Arachidonic Acid
- Obeticholic acid
- Chenodeoxycholic acid
- (8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid
- Myrrh
|
|
|
NR1I2 |
nuclear receptor subfamily 1 group I member 2 |
|
- Vitamin E
- Oxiconazole
- Phenytoin
- Diethylstilbestrol
- Clotrimazole
- Pentobarbital
- Spironolactone
- Lindane
- Flutamide
- Ritonavir
- Erlotinib
- Cyclophosphamide
- Mephenytoin
- Carbamazepine
- Tamoxifen
- Warfarin
- Ethotoin
- Estradiol
- Mifepristone
- Methylphenobarbital
- Ethinylestradiol
- Ketoconazole
- Fenofibrate
- Rifampicin
- Clonazepam
- Miconazole
- Nifedipine
- Econazole
- Sulfinpyrazone
- Phenobarbital
- Ifosfamide
- Rifaximin
- Paclitaxel
- Dexamethasone
- Docetaxel
- Bezafibrate
- Genistein
- Prasterone
- Hyperforin
- Resveratrol
- Pregnenolone
- Quercetin
- SR12813
- Afimoxifene
- Phenolphthalein
- Permethrin
- Dovitinib
- Chenodeoxycholic acid
- TO-901317
- Hexestrol
- Triclosan
- Rilpivirine
- Pyrethrum extract
- Myrrh
- Piperine
- Troleandomycin
- Fenofibric acid
- Estradiol acetate
- Estradiol benzoate
- Estradiol cypionate
- Estradiol dienanthate
- Estradiol valerate
- alpha-Tocopherol succinate
- D-alpha-Tocopherol acetate
- Dexamethasone acetate
|
|
|
NR1I3 |
nuclear receptor subfamily 1 group I member 3 |
|
- Doxylamine
- Meclizine
- Loperamide
- Ketoconazole
- Atorvastatin
- Pheniramine
- Prasterone
- 16,17-Androstene-3-Ol
- Resveratrol
- Cholesterol
- Phenolphthalein
- 3,20-Pregnanedione
- Hexestrol
- Triclosan
|
|
|
NR2F1 |
nuclear receptor subfamily 2 group F member 1 |
- Nuclear Receptor transcription pathway
|
|
|
|
NR2F6 |
nuclear receptor subfamily 2 group F member 6 |
- Nuclear Receptor transcription pathway
|
|
|
|
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
- HSP90 chaperone cycle for steroid hormone receptors (SHR)
- Circadian Clock
- SUMOylation of intracellular receptors
- PTK6 Expression
- Regulation of RUNX2 expression and activity
- FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
- Potential therapeutics for SARS
|
- Flunisolide
- Diflorasone
- Alclometasone
- Medrysone
- Amcinonide
- Fluorometholone
- Megestrol acetate
- Levonorgestrel
- Beclomethasone dipropionate
- Progesterone
- Spironolactone
- Betamethasone
- Desoximetasone
- Fluticasone propionate
- Fluocinolone acetonide
- Ulobetasol
- Triamcinolone
- Prednisone
- Flumethasone
- Fludrocortisone
- Norethisterone
- Hydrocortisone
- Mometasone
- Hydrocortamate
- Mifepristone
- Clocortolone
- Flurandrenolide
- Prednisolone
- Loteprednol etabonate
- Rimexolone
- Methylprednisolone
- Clobetasol propionate
- Fluocinonide
- Prednicarbate
- Fluoxymesterone
- Budesonide
- Dexamethasone
- Desonide
- Cortisone acetate
- Paramethasone
- Drospirenone
- Ciclesonide
- Hexane-1,6-Diol
- Aldosterone
- ORG-34517
- Difluprednate
- Ulipristal
- Fluticasone furoate
- Tixocortol
- Difluocortolone
- Gestrinone
- Deflazacort
- Onapristone
- Cortivazol
- Clobetasone
- Fluticasone
- Mometasone furoate
- Hydrocortisone aceponate
- Hydrocortisone acetate
- Hydrocortisone butyrate
- Hydrocortisone cypionate
- Hydrocortisone phosphate
- Hydrocortisone probutate
- Hydrocortisone valerate
- Segesterone acetate
- Prednisolone phosphate
- Dexamethasone acetate
- Betamethasone phosphate
- Prednisolone acetate
|
- 46,XX disorders of sex development (Disorders related to androgen excess), including: Congenital adrenal hyperplasias; Glucocorticoid resistance; Aromatase deficiency
|
|
NR3C2 |
nuclear receptor subfamily 3 group C member 2 |
- HSP90 chaperone cycle for steroid hormone receptors (SHR)
- SUMOylation of intracellular receptors
|
- Nimodipine
- Progesterone
- Spironolactone
- Fluticasone propionate
- Testosterone
- Fludrocortisone
- Eplerenone
- Clobetasol propionate
- Felodipine
- Desoxycorticosterone pivalate
- Drospirenone
- Stanolone
- Metribolone
- Aldosterone
- Corticosterone
- Desoxycorticosterone acetate
- Fluticasone furoate
- Fluticasone
- Testosterone cypionate
- Testosterone enanthate
- Testosterone undecanoate
- Stanolone acetate
|
- Hyperkalemic distal renal tubular acidosis (RTA type 4), including the following two diseases: Pseudohypoaldosteronism type I (PHA1); Pseudohypoaldosteronism type II (Gordon's syndrome)
- Hypertension exacerbated in pregnancy
|
|
NR4A1 |
nuclear receptor subfamily 4 group A member 1 |
- AKT phosphorylates targets in the nucleus
- Nuclear Receptor transcription pathway
- Constitutive Signaling by AKT1 E17K in Cancer
|
|
|
|
NR5A1 |
nuclear receptor subfamily 5 group A member 1 |
- Nuclear Receptor transcription pathway
- SUMOylation of intracellular receptors
- Transcriptional regulation of pluripotent stem cells
- Transcriptional regulation of testis differentiation
|
- (2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE
- Phosphatidyl ethanol
|
- Premature ovarian failure
- 46,XY disorders of sex development (Disorders of gonadal development), including: Gonadal agenesis; Complete and partial gonadal dysgenesis; Testis regression; Ovotesticular DSD
|
|
NR5A2 |
nuclear receptor subfamily 5 group A member 2 |
- Estrogen-dependent gene expression
|
|
|
|
NR6A1 |
nuclear receptor subfamily 6 group A member 1 |
|
|
|
|
PAGR1 |
PAXIP1 associated glutamate rich protein 1 |
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
|
|
|
|
PGR |
progesterone receptor |
- Nuclear signaling by ERBB4
- HSP90 chaperone cycle for steroid hormone receptors (SHR)
- Nuclear Receptor transcription pathway
- SUMOylation of intracellular receptors
- Estrogen-dependent gene expression
|
- Etonogestrel
- Desogestrel
- Megestrol acetate
- Levonorgestrel
- Dydrogesterone
- Progesterone
- Spironolactone
- Lindane
- Fluticasone propionate
- Medroxyprogesterone acetate
- Mitotane
- Norethisterone
- Mometasone
- Ethynodiol diacetate
- Mifepristone
- Norgestimate
- Drospirenone
- Danazol
- Oxybenzone
- Allylestrenol
- Phthalic Acid
- Metribolone
- Tanaproget
- Telapristone acetate
- Asoprisnil
- Norelgestromin
- Gestodene
- Hydroxyprogesterone caproate
- Ulipristal
- Fluticasone furoate
- Dienogest
- Medrogestone
- Norgestrel
- Homosalate
- Enzacamene
- Gestrinone
- Darolutamide
- Demegestone
- Fluticasone
- Mometasone furoate
- Segesterone acetate
|
|
|
PPARA |
peroxisome proliferator activated receptor alpha |
- RORA activates gene expression
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- PPARA activates gene expression
- PPARA activates gene expression
- Transcriptional activation of mitochondrial biogenesis
- Activation of gene expression by SREBF (SREBP)
- Transcriptional regulation of white adipocyte differentiation
- Nuclear Receptor transcription pathway
- Regulation of lipid metabolism by PPARalpha
- Circadian Clock
- SUMOylation of intracellular receptors
|
- alpha-Linolenic acid
- Icosapent
- Troglitazone
- Valproic acid
- Indomethacin
- Rosiglitazone
- Fenoprofen
- Clofibrate
- Fenofibrate
- Ibuprofen
- Amiodarone
- Gemfibrozil
- Bezafibrate
- Prasterone
- N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide
- Flufenamic acid
- Resveratrol
- Phthalic Acid
- Lauric acid
- Stearic acid
- Doconexent
- Palmitic Acid
- Oleic Acid
- Caprylic acid
- Arachidonic Acid
- Reglitazar
- Elafibranor
- Cardarine
- Muraglitazar
- Ertiprotafib
- Ragaglitazar
- Tesaglitazar
- GW-590735
- Indeglitazar
- Myristic acid
- Aleglitazar
- Clinofibrate
- Ciprofibrate
- Dexibuprofen
- Soybean oil
- Omega-3 fatty acids
- Myrrh
- Isoflavone
- Leukotriene B4
- Fenofibric acid
- Fish oil
|
|
|
PPARD |
peroxisome proliferator activated receptor delta |
- Carnitine metabolism
- Regulation of pyruvate dehydrogenase (PDH) complex
- Nuclear Receptor transcription pathway
- Signaling by Retinoic Acid
|
- alpha-Linolenic acid
- Icosapent
- Troglitazone
- Valproic acid
- Treprostinil
- Rosiglitazone
- Sulindac
- Bezafibrate
- Phthalic Acid
- Heptyl glucoside
- Oleic Acid
- cis-Vaccenic acid
- Elafibranor
- KD3010
- Cardarine
- (2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid
- 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid
- Indeglitazar
- {4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid
- Clinofibrate
- Glycerin
- Fenofibric acid
- Fish oil
|
|